"It's going to be a while before we can get in there and build anything," said Michael Hricak, an adjunct professor of architecture at the Universityof SouthernCalifornia, referring to the ...
A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder cancer are significantly improved by adding an immunotherapy drug to before ...